Welcome to LookChem.com Sign In|Join Free
  • or
Tert-butyl 2-(2-Hydroxyethyl)piperazine-1-carboxylate is a white to off-white crystalline powder that is a chemical compound belonging to the class of piperazine derivatives. It is recognized for its versatile reactivity and functional groups, which make it a valuable intermediate in the synthesis of pharmaceuticals and agrochemicals. tert-butyl 2-(2-Hydroxyethyl)piperazine-1-carboxylate is often utilized as a building block in the production of various drugs and other biologically active compounds, playing a crucial role in the development of medicinal and agricultural products.

517866-79-4

Post Buying Request

517866-79-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

517866-79-4 Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl 2-(2-Hydroxyethyl)piperazine-1-carboxylate is used as a key intermediate for the synthesis of various pharmaceuticals due to its ability to react with other chemicals to form biologically active compounds. Its versatile reactivity allows for the creation of a wide range of medicinal products.
Used in Agrochemical Industry:
In the agrochemical sector, tert-butyl 2-(2-Hydroxyethyl)piperazine-1-carboxylate is employed as a precursor in the production of agrochemicals, contributing to the development of compounds that can enhance crop protection and yield.
Used as a Building Block in Organic Synthesis:
Tert-butyl 2-(2-Hydroxyethyl)piperazine-1-carboxylate is used as a building block in organic synthesis for the creation of complex organic molecules, given its capacity to participate in various chemical reactions, thus expanding the scope of its applications in the chemical industry.
Due to its potential reactivity with other chemicals, it is imperative that tert-butyl 2-(2-Hydroxyethyl)piperazine-1-carboxylate is handled and stored with care, adhering to proper safety protocols to ensure the safety of personnel and the integrity of the compound.

Check Digit Verification of cas no

The CAS Registry Mumber 517866-79-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,1,7,8,6 and 6 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 517866-79:
(8*5)+(7*1)+(6*7)+(5*8)+(4*6)+(3*6)+(2*7)+(1*9)=194
194 % 10 = 4
So 517866-79-4 is a valid CAS Registry Number.

517866-79-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name tert-butyl 2-(2-hydroxyethyl)piperazine-1-carboxylate

1.2 Other means of identification

Product number -
Other names AS-D03

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:517866-79-4 SDS

517866-79-4Downstream Products

517866-79-4Relevant academic research and scientific papers

CYCLIC (AZA)INDOLIZINECARBOXAMIDES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS

-

Page/Page column 83, (2011/02/24)

The present invention relates to cyclic indolizinecarboxamides and azaindolizinecarboxamides of the formulae Ia and Ib, (Ia) (Ib) wherein R, Ra, R10, R20, R30, R40, Y, n, p and q have the meanings ind

Prenyl transferase inhibitors

-

, (2008/06/13)

A family of compounds capable of inhibiting the activity of prenyl transferases. The compounds are covered by the four following formulas Each of the R groups is defined in the disclosure.

Thioproline-containing inhibitors of farnesyl protein transferase

-

, (2008/06/13)

Inhibition of farnesyl transferase, which is an enzyme involved in ras oncogene expression, is effected b STR1 its enantiomers, diastereomers, and pharmaceutically acceptable salts and solvates thereof.

Inhibitors of farnesyl-protein transferase

-

, (2008/06/13)

The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras. The compounds of formula A are representative of the compounds of the present invention: STR1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 517866-79-4